{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:32:44Z","timestamp":1773297164126,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.ijpharm.2010.01.014","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T10:48:19Z","timestamp":1263898099000},"page":"41-52","source":"Crossref","is-referenced-by-count":14,"title":["Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims"],"prefix":"10.1016","volume":"389","author":[{"given":"A.","family":"Thai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Ammit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rohanizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2010.01.014_bib1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/jps.21195","article-title":"The influence of drug morphology on the aerosolisation efficiency of dry powder inhaler formulations","volume":"97","author":"Adi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib2","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1002\/jps.21239","article-title":"Cospray dried antibiotics for dry powder lung delivery","volume":"97","author":"Adi","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2008.05.009","article-title":"Micro-particle corrugation, adhesion and inhalation aerosol efficiency","volume":"35","author":"Adi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2003.11.001","article-title":"Theophylline particle design using chitosan by the spray drying","volume":"270","author":"Asada","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1164\/ajrccm.160.5.9809123","article-title":"Lung deposition and clearance of inhaled Tc-99m-heparin in healthy volunteers","volume":"160","author":"Bendstrup","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0305-4179(95)00096-8","article-title":"Early effects of smoke inhalation on alveolar macrophage functions","volume":"22","author":"Bidani","year":"1996","journal-title":"Burns"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0305-4179(03)00005-6","article-title":"Effects of rolling inhibition on smoke inhalation injury","volume":"29","author":"Cetin","year":"2003","journal-title":"Burns"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0169-409X(03)00078-4","article-title":"Novel alternative methods for the delivery of drugs for the treatment of asthma","volume":"55","author":"Chan","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/08942680152744703","article-title":"In vitro aerosol performance and dose uniformity between the Foradile (R) Aerolizer (R) and the Oxis (R) Turbuhaler (R)","volume":"14","author":"Chew","year":"2001","journal-title":"J. Aerol. Med."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11095-004-9020-4","article-title":"How much particle surface corrugation is sufficient to improve aerosol performance of powders?","volume":"22","author":"Chew","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib11","first-page":"339","article-title":"Heparin improves oxygenation and minimizes barotraumas after severe smoke-inhalation in an ovine model","volume":"176","author":"Cox","year":"1993","journal-title":"Surg. Gynecol. Obstet."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004630-199805000-00004","article-title":"Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin\/acetylcystine therapy","volume":"19","author":"Desai","year":"1998","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib13","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1097\/01.CCM.0000291647.18329.83","article-title":"Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation","volume":"35","author":"Enkhbaatar","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/CS20070254","article-title":"Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation","volume":"114","author":"Enkhbaatar","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib15","doi-asserted-by":"crossref","first-page":"A9","DOI":"10.1096\/fasebj.21.5.A9","article-title":"l-Arginine attenuates acute lung injury following smoke inhalation","volume":"21","author":"Enkhbaatar","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib16","series-title":"The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction","author":"Finlay","year":"2001"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0305-4179(88)90002-2","article-title":"Inhalation injury in burned patients\u2014effects and treatment","volume":"14","author":"Herndon","year":"1988","journal-title":"Burns"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib18","series-title":"Total Burn Care","article-title":"Inhalation injury","author":"Herndon","year":"2002"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BCR.0b013e31815f596b","article-title":"Use of inhaled heparin\/N-acetylcystine in inhalation injury: does it help?","volume":"29","author":"Holt","year":"2008","journal-title":"J. Burn Care Res."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3109\/01902148809087834","article-title":"Attenuation of endotoxin-induced cyto-toxicity and prostacyclin production in cultured bovine pulmonary-artery endothelial cells by phosphodiesterase inhibition","volume":"14","author":"Hussein","year":"1988","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib21","doi-asserted-by":"crossref","first-page":"L693","DOI":"10.1152\/ajplung.1994.267.6.L693","article-title":"Effects of TGF-Beta and TNF-Alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial-cells","volume":"267","author":"Idell","year":"1994","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/10611860410001659786","article-title":"Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy","volume":"11","author":"Li","year":"2003","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jgm.654","article-title":"The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy","volume":"7","author":"Li","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.burns.2005.11.006","article-title":"Theoretical evaluation of burns to the human respiratory tract due to inhalation of hot gas in the early stage of fires","volume":"32","author":"Lv","year":"2006","journal-title":"Burns"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib25","first-page":"200","article-title":"Respiratory care of the burn patient","volume":"26","author":"Mccall","year":"2005","journal-title":"J. Burn Care Rehabil."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/089426803772455622","article-title":"Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations","volume":"16","author":"Mitchell","year":"2003","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib27","first-page":"501","article-title":"Protective ventilator strategy improves pulmonary function in paediatric patients with inhalation injury","volume":"27","author":"Mlcak","year":"2001","journal-title":"Intens. Care Med."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.burns.2006.07.007","article-title":"Respiratory management of inhalation injury","volume":"33","author":"Mlcak","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/CS20020258","article-title":"High-dose heparin fails to improve acute lung injury following smoke inhalation in sheep","volume":"104","author":"Murakami","year":"2003","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00024382-200209000-00006","article-title":"Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep","volume":"18","author":"Murakami","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.ijpharm.2010.01.014_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2004.07.027","article-title":"The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine","volume":"285","author":"Najafabadi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/jsre.1994.1038","article-title":"The effects of pentoxifylline on pulmonary-function following smoke-inhalation","volume":"56","author":"Ogura","year":"1994","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib33","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1590\/S0100-879X2003001000011","article-title":"Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume","volume":"36","author":"Oliveira","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib34","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.1073\/pnas.0402891101","article-title":"Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route","volume":"101","author":"Qi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2005.09.004","article-title":"The influence of formulation components on the aerosolisation properties of spray-dried powders","volume":"110","author":"Rabbani","year":"2005","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib36","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jaerosci.2007.08.009","article-title":"Synthesis of L-leucine nanoparticles via physical vapor deposition at varying saturation conditions","volume":"38","author":"Raula","year":"2007","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0378-5173(02)00177-1","article-title":"Caffeine microparticles for nasal administration obtained by spray drying","volume":"242","author":"Sacchetti","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpharm.2003.09.041","article-title":"Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung","volume":"269","author":"Sham","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib39","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1002\/jps.21362","article-title":"Cospray-dried unfractionated heparin with l-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy","volume":"97","author":"Shur","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1094-5539(02)00147-5","article-title":"The inhalers of the future? A review of dry powder devices on the market today","volume":"16","author":"Smith","year":"2003","journal-title":"Pul. Pharm. Therap."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0169-409X(03)00079-6","article-title":"The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers","volume":"55","author":"Smyth","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib42","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","article-title":"Cellular and molecular regulation of tumor necrosis factor-Alpha production by pentoxifylline","volume":"155","author":"Strieter","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2010.01.014_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00003246-200203000-00024","article-title":"Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model","volume":"30","author":"Tasaki","year":"2002","journal-title":"Crit. Care Med."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517310000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517310000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T21:43:41Z","timestamp":1590529421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517310000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0378517310000475"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2010.01.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}